Intramuscular Oxytocin Investigated for Modulation of Autonomic Nervous System Activity in Healthy Individuals
Background
The autonomic nervous system (ANS) plays a crucial role in regulating involuntary bodily functions, including cardiovascular activity and pupil size. Dysregulation of the ANS is implicated in various psychiatric and neurological conditions. Heart rate variability (HRV), a measure of beat-to-beat changes in heart rate, reflects ANS balance, with higher HRV generally indicating better autonomic flexibility. Pupil diameter is also influenced by sympathetic and parasympathetic branches of the ANS. Oxytocin, a neuropeptide known for its roles in social bonding and stress regulation, has been hypothesized to modulate ANS activity, making it a candidate for investigating its effects on these physiological markers. Understanding oxytocin's impact on HRV and pupil dynamics could provide insights into its broader physiological and behavioral effects.
Study Design
This randomized, double-blind, basic science study enrolled an estimated 80 healthy participants to investigate the effects of intramuscular (IM) oxytocin. The primary objective was to assess oxytocin's influence on pupil diameter and heart rate variability (HRV), both indicators of autonomic nervous system activity. Secondary outcomes included evaluating oxytocin's impact on HRV during an emotion regulation task and on behavioral responses during the same task. The study design implies a placebo control arm, consistent with a double-blind methodology. No specific dose or frequency for oxytocin administration was detailed in the available record.
Results
The provided clinical trial record (NCT03055546) outlines the study's design and objectives but does not include any reported results or findings. Therefore, no specific data on the effects of intramuscular oxytocin on pupil diameter, heart rate variability, or behavioral responses during emotion regulation are available from this record. The study's status is currently UNKNOWN, and completion was estimated for March 2019, suggesting results may be pending or unpublished.
Why It Matters
Without reported findings, the direct implications for peptide users, biohackers, or clinicians cannot be determined. This study's design aims to explore a fundamental aspect of oxytocin's physiological effects on the autonomic nervous system. If positive findings emerge, they could inform future research into oxytocin's therapeutic potential for conditions involving ANS dysregulation or emotional processing. However, until results are published, no changes to current protocols or stacks are warranted, nor is there any immediate clinical translation outlook. The study's basic science nature suggests foundational insights rather than immediate clinical application.
oxytocin
heart rate variability
pupil diameter
autonomic nervous system
healthy
clinical trial
